Sep 09, 2021 7:00am EDT Can-Fite to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 26, 2021 7:00am EDT Can-Fite Reports Second Quarter 2021 Financial Results & Provides Clinical Update
Aug 05, 2021 9:18am EDT Yossi Borenstein, CEO and Founder of Shizim Group, has been Elected to the Can-Fite Board
Jun 28, 2021 7:00am EDT Can-Fite Enters Projected $3 Billion Veterinary Osteoarthritis Market: Signs Agreement with Vetbiolix for Development of Piclidenoson for Pets
Jun 02, 2021 7:35am EDT Can-Fite To Initiate Phase IIb NASH Study with its Drug Candidate Namodenoson
Jun 02, 2021 7:00am EDT Can-Fite to Present at BIO Digital International Convention & Conduct One-on-One Meetings with Potential Partners on June 10-18, 2021
